Since then, reverse genetic tools have seen unprecedented growth rates with the introduction of TALEN and CRISPR-Cas9 systems, including an apoea knockout for AD [119] and a tardbp knockin and fus knockin for ALS [40,120] (Table 3). This evidence concerns the gene TARDBP and Alzheimer disease.